[1]
Suryanarayana Rao, K. 2017. Preclinical Safety Considerations for Biosimilars. Biology, Engineering, Medicine and Science Reports. 3, 2 (Jul. 2017), 67–69. DOI:https://doi.org/10.5530/bems.3.2.8.